newsfilter
← Latest News
Business Wire·

PharmaCyte Biotech Announces Additional Quality Control Assay and Confirms Stability of CypCap Cells

PharmaCyte Biotech, Inc. (NASDAQ:PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced the results of a